No ‘causal’ link found yet between J&J vaccine and blood clots: US health authorities

(FILES) In this file photo taken on March 5, 2021, registered nurse Florisa N. Lingad holds a Johnson & Johnson Covid-19 vaccine at a vaccination center established at the Hilton Chicago O'Hare Airport Hotel in Chicago, Illinois. - The European Medicines Agency said on March 9, 2021, that it is set to decide whether to authorize Johnson & Johnson's Janssen single-shot coronavirus vaccine for the EU on March 11. If approved by the Amsterdam-based regulator, the vaccine would be the fourth to get the green light for the 27-nation bloc, in a boost for its slow-starting vaccination program. (Photo by KAMIL KRZACZYNSKI / AFP)

(FILES) In this file photo taken on March 5, 2021, registered nurse Florisa N. Lingad holds a Johnson & Johnson Covid-19 vaccine at a vaccination center established at the Hilton Chicago O’Hare Airport Hotel in Chicago, Illinois. (Photo by KAMIL KRZACZYNSKI / AFP)

WASHINGTON — Top US health authorities said Friday they have not yet found a “causal” link between Johnson & Johnson’s coronavirus shot and blood clots, as the EU drug regulator probed possible instances among those who have received the vaccine.

“At this time, we have not found a causal relationship with vaccination and we are continuing our investigation and assessment of these cases,” said a statement from the US Food and Drug Administration.

The regulatory agency said it was aware of “a few individuals” in the United States who had suffered clots and low levels of platelets in the blood after receiving J&J’s vaccine.

“Both conditions can have many different causes,” the FDA said. “We will keep the public updated as we learn more.”

Four cases, one fatal, of rare clots with low blood platelets were reported among those vaccinated with the Johnson & Johnson shot, the European Medicines Agency (EMA) said in a statement.

Read more...